Children’s Specialized Hospital’s Distinguished Lecture Series: Dr. Wise Young Presents Cutting Edge Spinal Cord Injury Research
October 14, 2016
Children’s Specialized Hospital announces the next lecture in their Distinguished Lecture Series. Dr. Wise Young's presentation titled: "Update on Trials of Umbilical Cord Blood and Lithium Treatments of Spinal Cord Injury" will be held on Tuesday, November 1, at noon at PSE&G Children’s Specialized Hospital, 200 Somerset Street in New Brunswick.
Children’s Specialized Hospital welcomes all physicians, researchers, therapists, and other health care professionals to attend this free lecture. This research education program is free for health care professionals and gives participants the opportunity to meet world-renowned doctors and scientists specializing in a variety of research areas and working on studies affecting the health care industry today.
Dr. Young is the founding director of the WM Keck Center for Collaborative Neuroscience and Richard H. Shindell Chair in Neuroscience at Rutgers University. Dr. Young is committed to bringing treatments to people with spinal cord Injuries. Dr. Young led the team that discovered and established high-dose methylprednisolone (MP) as the first effective therapy for spinal cord injuries. This 1990 work upended concepts that spinal cord injuries were permanent, refocused research, and opened new vistas of hope. He built and trained a twenty-five center clinical trial network in China, Taiwan, and Hong Kong where human clinical trials using umbilical cord blood mononuclear cells and lithium are underway. He is establishing clinical trial networks in the United States, Norway, and India and will start Phase IIB Trials in 2016-2017.
Children’s Specialized Hospital understands the important role education and research play in health care to facilitate ground-breaking discoveries that will change the lives of people and families for years to come. Children’s Specialized Hospital Research Center has created an innovative, unique, and exciting opportunity for all health care professionals to learn more about featured topics and research projects.
”The Distinguished Lecture Series was created to bring together basic, translational, and clinical research to advance pediatric rehabilitation,” said Michael Dribbon, PhD, VP of Business and Program Development at Children’s Specialized Hospital. “We are honored and excited to welcome these highly respected researchers to our hospital and offer this resource to our network of medical professionals and researchers.”
Register online by October 27, 2016 here or contact Claire Marchetta, Research Liaison, at: email@example.com or (732) 258-7288. For additional information, visit: www.childrens-specialized.org/research.
Children’s Specialized Hospital is the nation’s leading provider of inpatient and outpatient care for children from birth to 21 years of age facing special health challenges — from chronic illnesses and complex physical disabilities like brain and spinal cord injuries, to developmental and behavioral issues like autism and mental health. At twelve different New Jersey locations, our pediatric specialists partner with families to make our many innovative therapies and medical treatments more personalized and effective...so children can achieve more of their goals. To help, or find more information: call 888-CHILDRENS; visit www.childrens-specialized.org; Facebook: www.facebook.com/childrensspecialized; Twitter: www.twitter.com/childrensspecnj; YouTube: www.youtube.com/cshnj; LinkedIn: www.linkedin.com/company/children's-specialized-hospital